IL1B and neoplasm: TIDC have been shown to serve as tumor suppressors in the early stages by secreting pro-inflammatory cytokines such as TNF-α, IL-1, IL-12, and IL-23, but as tumor promoters in the later stages [28,29,30,31,32].